bit.bio, a leader in synthetic biology focused on coding human cells for innovative therapies, has successfully defended its foundational European patent for opti-ox. This groundbreaking technology allows for the deterministic…
MEDiC Life Sciences, a Silicon Valley biotech startup, has announced a research collaboration with Hanmi Pharmaceutical, a prominent biopharma company based in Korea. Through this partnership, MEDiC will utilize its…
Pfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis. This treatment is designed to prevent or reduce the…
Reproductive Medicine Associates (RMA), a leading provider in reproductive services and a pioneer in IVF research, proudly celebrated its 25th anniversary this month. Over the past quarter-century, RMA has made…
Wysa, a global leader in AI-driven mental health support, has announced the launch of the Safety Assessment for LLMs in Mental Health (SAFE-LMH) initiative. Unveiled on World Mental Health Day,…
HCA Healthcare, Inc. (NYSE: HCA), a leading healthcare provider in the U.S., has announced a $1 million donation to support Hurricane Helene relief efforts in North Carolina through community organizations.…
TheraVectys, a biotechnology firm focused on creating lentiviral vector-based vaccines and immunotherapies for infectious diseases and cancers, has announced the enrollment of the first patient in a Phase I/IIa clinical…
Aulos Bioscience, an immuno-oncology company focused on advancing cancer care through innovative IL-2 therapeutics, has announced the presentation of encouraging safety and efficacy data from the Phase 2 dose expansion…
Summit Therapeutics Inc. (NASDAQ: SMMT) has announced the completion of patient enrollment in its HARMONi clinical trial. This multi-regional Phase III study evaluates ivonescimab combined with platinum-doublet chemotherapy versus placebo…
CureMetrix® has announced a new peer-reviewed study confirming the effectiveness of its investigational AI-enabled software for automated breast arterial calcification (BAC) detection in mammograms. This technology can inform personalized risk…
StemCardia Inc. has secured a license for a range of intellectual property from CoMotion at the University of Washington (UW) and the UW School of Medicine, focusing on next-generation treatments…
Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of health care solutions for dental and medical practitioners, has unveiled the “Prepare to Care” initiative through the Henry Schein Cares Foundation,…